Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NexGen® TM Tibia Clinical Outcomes Study: Prospective Multicenter Study of the NexGen® TM Monoblock and Modular Tibias

NCT03272373 is registered in ClinicalTrials.gov with Zimmer Biomet as lead sponsor.

NCT NCT03272373
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03272373 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NexGen® TM Tibia Clinical Outcomes Study: Prospective Multicenter Study of the NexGen® TM Monoblock and Modular Tibias
Lead sponsor
Zimmer Biomet
Phase
Not applicable
Overall status
Completed
Start date
October 3, 2017
Completion date
March 31, 2023
Enrollment
160 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

collagen disorders and/or avascular necrosis of the femoral condyle, moderate valgus, varus, or flexion deformities, osteoarthritis, polyarthritis, post-traumatic loss of joint configuration, rheumatoid arthritis, traumatic arthritis